QuellTX
George Eleftheriadis has a diverse work experience. George started working at King's College London in December 2018 as a Postdoctoral Researcher and stayed in that role until March 2020. In April 2020, they joined UK Biocentre as a Frontline Worker and worked there until June 2020. From July 2020 to December 2021, George worked at Quell Therapeutics, initially as an R&D Scientist I and later as an R&D Scientist II.
George Eleftheriadis began their education journey in 2003 at The University of Edinburgh, where they pursued a Bachelor of Science with Honours in Neuroscience. George successfully completed this program in 2007. In 2007, George embarked on a Master of Research program in Genomics and Pathway Biology at the same university, which concluded in 2008. Following this, they attended UCL from 2011 to 2012 to obtain a Master of Research degree in Cell and Developmental Biology. Finally, George pursued a Doctor of Philosophy degree in Neuroinflammation at Queen's University Belfast from 2014 to 2018.